{
    "pmcid": "8463300",
    "qa_pairs": {
        "How many distinct epitope clusters were identified on the RBD of the SARS-CoV-2 spike protein?": [
            "Six",
            "Four",
            "Eight",
            "Ten"
        ],
        "What is the primary mechanism of neutralization for antibodies targeting the SARS-CoV-2 spike protein?": [
            "Blocking the interaction between the RBD and ACE2 receptor",
            "Inhibiting viral replication within host cells",
            "Preventing viral RNA synthesis",
            "Disrupting viral membrane integrity"
        ],
        "What strategy is suggested for developing robust therapeutic interventions against SARS-CoV-2?": [
            "Combining non-competing mAbs targeting different RBD epitopes",
            "Using single mAbs with high affinity for the RBD",
            "Developing vaccines targeting the N protein",
            "Employing antiviral drugs that inhibit viral proteases"
        ],
        "What structural techniques were used to analyze antibody-RBD interactions in the study?": [
            "X-ray crystallography and cryo-EM",
            "NMR spectroscopy and mass spectrometry",
            "Fluorescence microscopy and flow cytometry",
            "Atomic force microscopy and electron tomography"
        ],
        "Which germline-derived antibody class is noted for its resilience against mutations at key RBD residues E484 and K417?": [
            "VH1-58",
            "VH3-53/66",
            "VH4-34",
            "VH5-51"
        ]
    }
}